Abstract: A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of L-arginine, omega-3 fatty acids, vitamin A, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to a bladder surgery of the patient to a post-operative day that is three to seven days after the bladder surgery. The supplement can be administered to treat or prevent post-operative paralytic ileus in a bladder cancer patient; treat or prevent surgery-induced, inflammation-induced or cancer-induced cachexia; reduce the incidence of chronic infections resulting from expansion of myeloid-derived suppressor cells in a patient; and/or reduce mRNA expression of pro-inflammatory cytokines in a patient.

Abstract: A composition comprising medium-chain triglycerides (MCTs) wherein the composition comprises (i) a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8) and (ii) a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10); wherein the ratio of MCT-C8 to MCT-C10 is from 10:90 to 90:10 (mol/mol) and wherein the combined amount of MCT-C8 and MCT-C10 make up at least 50 mol % of the MCTs in the composition.

Abstract: Use of a lentil product to increase the bioavailability of non-haem iron in a composition comprising one or more anti-nutritional factors.

Abstract: A capsule for preparation of a beverage can include a container and a beverage ingredient contained therein. The container can include at least one support having a section on which a plurality of sequences of symbols is represented; each symbol is sequentially readable, by a reading arrangement of an external device, while the capsule is rotated along an axis of rotation. Each sequence can code a set of information related to the capsule, and at least one of the sequences can include symbols defining a preamble sequence that allows determination of a position of the symbols in the associated sequence coding the set of information related to the capsule. The container can include a cup-shaped body having a flange-like rim and a lid connected to the body, the support can be on a bottom of the rim, and the bottom of the rim can be opposed to the lid.

Abstract: The invention relates to a product container (1) for multiple dosing of a food product, comprising an inner volume (3) with a food product, this inner volume (3) being pressurized with nitrogen gas; the product container (1) further comprising a rotatable outlet element (7, 30) able to move from a position where the outlet of the container is open to a position where the outlet of the container is closed, being able to open and close the volume of the container under pressure; the pressure inside the container being higher than the atmospheric pressure.

Abstract: A method of treating a gastrointestinal disorder includes administering to a patient an effective amount of a multiparticulate dosage form including a plurality of individual spheroidal enteric coated cores having a diameter of 0.1 mm to 3 mm. The individual spheroidal enteric coated cores have (a) a core including menthol, (b) a proteinaceous subcoating over the core, and (c) an enteric coating over the proteinaceous subcoating. The multiparticulate dosage form is configured to release most of the menthol in the area of the GI tract where the inflammation is occurring.

Abstract: A capsule beverage machine (1) has: a passage (2) for evacuating used capsules (100); a capsule collector (10) having a bottom (11) and sidewalls (12,12?) delimiting a cavity (13) with a cavity entry opening (14) and a cavity volume for storing the used capsules (100); and a seat (20) into which the evacuation passage (2) leads, the collector (10) having a collection position in which the collector (10) is removably located in the seat (20) for collecting capsules (100) delivered via the passage (2) and the entry opening (14). The seat (20) and the collector (10) are configured to adjust the cavity volume of the cavity (13) so that the cavity volume is smaller when the collector (10) is located in the seat and larger at removal of the collector (10) from the seat. The sidewalls (12,12?) include at least one sidewall (12?) that is movably mounted in the collector (10). The seat (20) and/or the movable sidewall (12?) has an interacting seat member (21).

Abstract: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.

Abstract: A method for roasting coffee beans comprising the steps of a) heating the coffee beans until the temperature of the coffee beans is at least 180° C.; b) injecting a stream of oxygen-containing gas into the flow of hot air after the burner; and c) maintaining the injection of the stream of oxygen-containing gas until the end of the roasting process to mitigate the concentration of carbon monoxide in the roasting chamber, and wherein the coffee beans are roasted in a rotating fluidized bed roaster.

Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.

Abstract: The present invention relates to flavour generation. In particular the invention relates to a method for flavour generation in a heat-treated food product using a prolidase enzyme. The invention also relates to a heat-treated food product prepared according to the method of the invention.

Abstract: Medium chain fatty acids or a composition comprising medium chain fatty acids for use in the prevention or treatment of cardiac enlargement, valvular heart disease and/or a condition associated with either of the foregoing in a human.

Abstract: The present invention relates to a soluble beverage powder of dried coffee extract. In particular to a soluble coffee powder having a gold appearance. Further aspects of the invention are a powder mix for preparing a beverage and a process for making a soluble beverage powder.

Abstract: The present invention relates to a composition comprising a dispersion of dietary fibre particles in fat. In particular, a composition wherein the dietary fibre particles comprise water. Further aspects of the invention include the use of the composition to reduce saturated fatty acid content, a process for preparing the composition and a food product.

Abstract: The present invention relates to a dispensing device (10) for dispensing a food product from a exchangeable multi-dose container (1), the device comprising a support (9) for removably supporting the container (1), a sealable dosing chamber (4) for receiving, dosing and holding a dose of food product dispensed from the container (1), oxygen reducing means (5) designed for reducing oxygen level in the dosing chamber (4), characterized in that the device further comprises at least one piston (7) arranged to move relatively to the support (9) of the device, and configured to at least partially enclose the dosing chamber (4) in an initial sealingly engaged position of the piston with the support (9), the piston (7) being designed for selectively opening the container (1) by moving relatively to the support (8) and for enabling the dosing chamber (4) to be charged with the dose of food product in an extended and sealingly disengaged position of the piston (7) relative to the support (9).

Abstract: A mobile liquid tank is disclosed that includes an insulated tank body and two heating elements. Also disclosed is a liquid heating system comprising the mobile liquid tank, as well as methods of heating a liquid using the mobile liquid tank.

Abstract: A pet food composition specifically formulated for a small dog can include a combination of specific amino acids and probiotics to maintain or increase absorption of amino acids. Methods of increasing absorption of amino acids are also provided.

Abstract: The invention concerns a process for preparing a tea in a drinking receptacle with a tea brewing machine, said machine being configured:—to brew tea from a capsule, said capsule comprising tea leaves, by introducing hot water in said capsule and dispensing brewed tea from the capsule in the drinking receptacle, and—to pump and heat water and dispense hot water to the capsule, wherein said process comprises a step of pasteurization of tea leaves inside the capsule before dispensing brewed tea from the capsule inside the drinking receptacle, wherein said pasteurization step comprises the sub-steps of: p1)—introducing hot water in the capsule until all the tea leaves are submerged by hot water inside the capsule and stopping water introduction before tea is dispensed therefrom in the drinking receptacle, then p2) keeping all the tea leaves submerged in hot water during a period of time, wherein the temperature of hot water introduced in sub-step p1) and the sum of the periods of time of sub-steps p1) and p2) bef

Abstract: A process for reducing the monosaccharide and/or disaccharide content in a food material, the process comprising contacting the food material with a glucosyltransferase that comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 1.